Porcu, G. http://orcid.org/0000-0002-9871-4129
Biffi, A.
Ronco, R.
Adami, G.
Alvaro, R.
Bogini, R.
Caputi, A. P.
Frediani, B.
Gatti, D.
Gonnelli, S.
Iolascon, G.
Lenzi, A.
Leone, S.
Michieli, R.
Migliaccio, S.
Nicoletti, T.
Paoletta, M.
Pennini, A.
Piccirilli, E.
Rossini, M.
Tarantino, U.
Cianferotti, L.
Brandi, M. L.
Corrao, G.
Funding for this research was provided by:
Università degli Studi di Milano - Bicocca
Article History
Received: 19 June 2023
Accepted: 10 October 2023
First Online: 3 November 2023
Declarations
:
: GA declares personal fees from Theramex, Amgen, BMS, Lilly, Fresenius Kabi, and Galapagos. LC declares personal fees from UCB Pharma, Abiogen Pharma, Bruno Farmaceutici, Sandoz, Metagenics. DG has received honoraria as consultant for Eli Lilly, Organon, MSD Italia. SG has received honoraria as consultant for UCB Pharma. SM has received honoraria as consultant for UCB, Eli Lilly, Amgen. MLB has received (i) honoraria from Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB, (ii) grants and/or speaker: Abiogen, Alexion, Amgen, Bruno Farmaceutici, Echolight, Eli Lilly, Kyowa Kirin, SPA, Theramex, UCB Pharma, (iii) consultant: Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB Pharma. GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS). He also received honoraria as member of Advisory Board from Roche. No other potential conflicts of interest relevant to this article were disclosed. MR declares personal fees from Amgen, ABBvie, BMS, Eli Lilly, Galapagos, Menarini, Novartis, Pfizer, Sandoz, Theramex, and UCB outside the submitted work. RM took part to a project funded by Abiogen Pharma. GI received honoraria as speaker by Eli Lilly, Menarini, UCB Pharma. The other authors declare that they have no conflict of interest. All authors have completed the ICMJE uniform disclosure form at ExternalRef removed (available on request from the corresponding author) and declare no conflicts of interest.
: This research was done without patient involvement. Patients were not invited to comment on the study design and were not consulted to develop patient-relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy.
: For this type of study, formal consent is not required.